Review Article | Published:

Childhood obesity and cardiovascular disease: links and prevention strategies

Nature Reviews Cardiology volume 8, pages 513525 (2011) | Download Citation

Abstract

The prevalence and severity of pediatric obesity have dramatically increased since the late 1980s, raising concerns about a subsequent increase in cardiovascular outcomes. Strong evidence, particularly from autopsy studies, supports the concept that precursors of adult cardiovascular disease (CVD) begin in childhood, and that pediatric obesity has an important influence on overall CVD risk. Lifestyle patterns also begin early and impact CVD risk. In addition, obesity and other CVD risk factors tend to persist over time. However, whether childhood obesity causes adult CVD directly, or does so by persisting as adult obesity, or both, is less clear. Regardless, sufficient data exist to warrant early implementation of both obesity prevention and treatment in youth and adults. In this Review, we examine the evidence supporting the impact of childhood obesity on adult obesity, surrogate markers of CVD, components of the metabolic syndrome, and the development of CVD. We also evaluate how obesity treatment strategies can improve risk factors and, ultimately, adverse clinical outcomes.

Key points

  • The prevalence and severity of pediatric obesity have dramatically increased since the late 1980s

  • Precursors of adult cardiovascular disease begin in childhood, with obesity as an important correlate of overall cardiovascular risk

  • Lifestyle patterns begin early in childhood and influence cardiovascular risk

  • Obesity and other cardiovascular risk factors persist over time

  • Obesity prevention and reduction should begin early in childhood to prevent adult cardiovascular disease

  • The pervasive nature of adult cardiovascular disease translates to an urgent need for new population-based obesity-prevention strategies

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Centers for Disease Control and Prevention. Growth charts [online], , (2010).

  2. 2.

    et al. Prevalence of overweight and obesity in the United States, 1999–2004 JAMA 295, 1549–1555 (2006).

  3. 3.

    & The global spread of type 2 diabetes mellitus in children and adolescents. J. Pediatr. 146, 693–700 (2005).

  4. 4.

    et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N. Engl. J. Med. 338, 1650–1656 (1998).

  5. 5.

    et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105, 2712–2718 (2002).

  6. 6.

    et al. Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 102, 374–379 (2000).

  7. 7.

    et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) 18, 377–383 (2010).

  8. 8.

    et al. Life-time risk factors and progression of carotid atherosclerosis in young adults: the Cardiovascular Risk in Young Finns study. Eur. Heart J. 31, 1745–1751 (2010).

  9. 9.

    et al. Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study. Hypertension 55, 806–811 (2010).

  10. 10.

    , , , & Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am. J. Clin. Nutr. 67, 1111–1118 (1998).

  11. 11.

    , & Childhood body-mass index and the risk of coronary heart disease in adulthood. N. Engl. J. Med. 357, 2329–2337 (2007).

  12. 12.

    , , , & Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N. Engl. J. Med. 327, 1350–1355 (1992).

  13. 13.

    , , , & Effectiveness of weight management interventions in children: a targeted systematic review for the USPSTF. Pediatrics 125, e396–e418 (2010).

  14. 14.

    , , , & Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics 108, 712–718 (2001).

  15. 15.

    et al. Stability of the association between birth weight and childhood overweight during the development of the obesity epidemic. Obes. Res. 13, 2187–2194 (2005).

  16. 16.

    , , & The relation of parental cardiovascular disease to risk factors in children and young adults. The Bogalusa Heart Study. Circulation 91, 365–371 (1995).

  17. 17.

    et al. Size at birth, maternal weight, and type 2 diabetes in South India. Diabet. Med. 15, 220–227 (1998).

  18. 18.

    Outcome of low birthweight. Horm. Res. 42, 223–230 (1994).

  19. 19.

    et al. The association of birth weight with developmental trends in blood pressure from childhood through mid-adulthood: the Bogalusa Heart study. Am. J. Epidemiol. 166, 413–420 (2007).

  20. 20.

    & Adiposity in Czech children followed from 1 month of age to adulthood: analysis of individual BMI patterns. Ann. Hum. Biol. 20, 517–525 (1993).

  21. 21.

    & Patterns of growth associated with the timing of adiposity rebound. Obesity (Silver Spring) 17, 335–341 (2009).

  22. 22.

    , , , & Early adiposity rebound in childhood and risk of type 2 diabetes in adult life. Diabetologia 46, 190–194 (2003).

  23. 23.

    , , , & BMI rebound, childhood height and obesity among adults: the Bogalusa Heart Study. Int. J. Obes. Relat. Metab. Disord. 25, 543–549 (2001).

  24. 24.

    , , , Risk of obesity in relation to physical activity tracking from youth to adulthood. Med. Sci. Sports Exerc. 38, 919–925 (2006).

  25. 25.

    et al. Effects of persistent physical activity and inactivity on coronary risk factors in children and young adults. The Cardiovascular Risk in Young Finns Study. Am. J. Epidemiol. 140, 195–205 (1994).

  26. 26.

    et al. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J. Clin. Endocrinol. Metab. 94, 3687–3695 (2009).

  27. 27.

    Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113, 2335–2362 (2006).

  28. 28.

    , , & Vascular biomarkers and surrogates in cardiovascular disease. Circulation 113, 2936–2942 (2006).

  29. 29.

    et al. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 54, 919–950 (2009).

  30. 30.

    et al. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 101, E16–E22 (2000).

  31. 31.

    et al. Race (black-white) and gender divergences in the relationship of childhood cardiovascular risk factors to carotid artery intima–media thickness in adulthood: the Bogalusa Heart Study. Atherosclerosis 194, 421–425 (2007).

  32. 32.

    et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA 290, 2271–2276 (2003).

  33. 33.

    et al. The contribution of childhood obesity to adult carotid intima–media thickness: the Bogalusa Heart Study. Int. J. Obes. (Lond.) 32, 749–756 (2008).

  34. 34.

    et al. Cardiovascular risk factors in childhood and carotid artery intima–media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 290, 2277–2283 (2003).

  35. 35.

    , , & Carotid intimal–medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circulation 104, 2815–2819 (2001).

  36. 36.

    , , , & Risk factors associated with aortic and carotid intima–media thickness in adolescents and young adults: the Muscatine Offspring Study. J. Am. Coll. Cardiol. 53, 2273–2279 (2009).

  37. 37.

    et al. for the MESA Study Investigators. Coronary artery calcification and myocardial perfusion in asymptomatic adults: the MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 48, 1018–1026 (2006).

  38. 38.

    et al. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J. Am. Coll. Cardiol. 27, 277–284 (1996).

  39. 39.

    , & Usefulness of electron beam tomography in adolescents and young adults with heterozygous familial hypercholesterolemia. Circulation 98, 2580–2583 (1998).

  40. 40.

    et al. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J. Am. Coll. Cardiol. 42, 1037–1043 (2003).

  41. 41.

    et al. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 20, 2070–2075 (2000).

  42. 42.

    et al. Overweight in children is associated with arterial endothelial dysfunction and intima–media thickening. Int. J. Obes. Relat. Metab. Disord. 28, 852–857 (2004).

  43. 43.

    , , , & Impact of multiple cardiovascular risk factors on brachial artery distensibility in young adults: the Bogalusa Heart Study. Am. J. Hypertens. 18, 767–771 (2005).

  44. 44.

    et al. Measures of brachial artery distensibility in relation to coronary calcification. Am. J. Hypertens. 16, 350–355 (2003).

  45. 45.

    et al. Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation 101, 1533–1538 (2000).

  46. 46.

    et al. Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation 112, 1789–1797 (2005).

  47. 47.

    , & The metabolic syndrome. Lancet 365, 1415–1428 (2005).

  48. 48.

    et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 119, 628–647 (2009).

  49. 49.

    et al. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350, 2362–2374 (2004).

  50. 50.

    et al. Childhood overweight and cardiovascular disease risk factors: the National Heart, Lung, and Blood Institute Growth and Health Study. J. Pediatr. 150, 18–25 (2007).

  51. 51.

    , & Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: the Princeton Lipid Research Clinics Follow-up Study. Pediatrics 120, 340–345 (2007).

  52. 52.

    , , & Childhood predictors of the metabolic syndrome in middle-aged adults: the Muscatine Study. J. Pediatr. 155, S5.e17–S5.e26 (2009).

  53. 53.

    et al. Childhood obesity predicts adult metabolic syndrome: the Fels Longitudinal Study. J. Pediatr. 152, 191–200 (2008).

  54. 54.

    , , & Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. Arch. Intern. Med. 154, 1842–1847 (1994).

  55. 55.

    , , & Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. Metabolism 45, 235–240 (1996).

  56. 56.

    , , , & Clustering of long-term trends in metabolic syndrome variables from childhood to adulthood in Blacks and Whites: the Bogalusa Heart Study. Am. J. Epidemiol. 166, 527–533 (2007).

  57. 57.

    , , , & Predictive ability of childhood metabolic components for adult metabolic syndrome and type 2 diabetes. J. Pediatr. 155, S6.e1–S6.e7 (2009).

  58. 58.

    , , & Additive utility of family history and waist circumference to body mass index in childhood for predicting metabolic syndrome in adulthood. J. Pediatr. 155, S6.e9–S6.e13 (2009).

  59. 59.

    et al. Prediction of coronary artery calcium in young adults using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) risk score: the CARDIA study. Arch. Intern. Med. 166, 2341–2347 (2006).

  60. 60.

    , , & Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 25, 2184–2190 (2002).

  61. 61.

    et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334, 952–957 (1996).

  62. 62.

    et al. Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. Endocrinology 139, 4067–4072 (1998).

  63. 63.

    , , , & Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. J. Clin. Endocrinol. Metab. 87, 1419–1422 (2002).

  64. 64.

    , , , & Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J. Clin. Endocrinol. Metab. 80, 172–178 (1995).

  65. 65.

    , , & Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention. Am. J. Clin. Nutr. 84, 490–496 (2006).

  66. 66.

    et al. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J. Clin. Endocrinol. Metab. 94, 3687–3695 (2009).

  67. 67.

    , , , & Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J. Clin. Endocrinol. Metab. 88, 2534–2540 (2003).

  68. 68.

    , & Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 93, 54–59 (1996).

  69. 69.

    et al. Insulin and blood pressure among healthy children. Cardiovascular risk in young Finns. Am. J. Hypertens. 9, 194–199 (1996).

  70. 70.

    et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 111, 1985–1991 (2005).

  71. 71.

    et al. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study. Diabetologia 38, 1042–1050 (1995).

  72. 72.

    , , & Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch. Intern. Med. 167, 642–648 (2007).

  73. 73.

    et al. Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism 35, 441–446 (1986).

  74. 74.

    et al. Relation of serum lipoprotein lipids and apolipoproteins to obesity in children: the Bogalusa Heart Study. Prev. Med. 21, 177–190 (1992).

  75. 75.

    , & Relation of obesity to insulin secretion and clearance in adolescents: the Bogalusa Heart Study. Int. J. Obes. Relat. Metab. Disord. 20, 951–956 (1996).

  76. 76.

    , , & The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 103, 1175–1182 (1999).

  77. 77.

    , , , & Adiposity in childhood predicts obesity and insulin resistance in young adulthood. J. Pediatr. 138, 469–473 (2001).

  78. 78.

    , , & Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study. Circulation 99, 1471–1476 (1999).

  79. 79.

    , & Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: the Bogalusa Heart Study. Metabolism 48, 928–934 (1999).

  80. 80.

    , & Insulin resistance during puberty and future fat accumulation. J. Clin. Endocrinol. Metab. 87, 3814–3818 (2000).

  81. 81.

    & Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 369, 1823–1831 (2007).

  82. 82.

    et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J. Pediatr. 136, 664–672 (2000).

  83. 83.

    et al. Secular trends in blood pressure during early-to-middle adulthood: the Fels Longitudinal Study. J. Hypertens. 29, 838–845 (2011).

  84. 84.

    et al. Progression of normotensive adolescents to hypertensive adults: a study of 26,980 teenagers. Hypertension 56, 203–209 (2010).

  85. 85.

    et al. The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima–media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study. J. Am. Coll. Cardiol. 53, 860–869 (2009).

  86. 86.

    et al. Associations of dyslipidemias from childhood to adulthood with carotid intima–media thickness, elasticity, and brachial flow-mediated dilatation in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler. Thromb. Vasc. Biol. 28, 1012–1017 (2008).

  87. 87.

    , , & Risk factors and adult body mass index among overweight children: the Bogalusa Heart Study. Pediatrics 123, 750–757 (2009).

  88. 88.

    et al. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study. Circulation 117, 32–42 (2008).

  89. 89.

    Prevalence of fatty liver in children and adolescents. Pediatrics 118, 1388–1393 (2006).

  90. 90.

    , & Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J. Pediatr. Gastroenterol. Nutr. 41, 94–98 (2005).

  91. 91.

    et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42, 641–649 (2005).

  92. 92.

    et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 53, 2855–2860 (2004).

  93. 93.

    , , & Insulin resistance in nonalcoholic fatty liver disease. Curr. Pharm. Des. 16, 1941–1951.

  94. 94.

    et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54, 3541–3546 (2005).

  95. 95.

    , , , & Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 56, 792–798 (2007).

  96. 96.

    et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499–511 (2003).

  97. 97.

    et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111, 747–753 (2005).

  98. 98.

    , & Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109, 2818–2825 (2004).

  99. 99.

    et al. Distribution and metabolic syndrome correlates of plasma C-reactive protein in biracial (black-white) younger adults: the Bogalusa Heart Study. Metabolism 55, 699–705 (2006).

  100. 100.

    et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care 28, 1763–1768 (2005).

  101. 101.

    et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149, 139–150 (2000).

  102. 102.

    , , , & Adolescent overweight and future adult coronary heart disease. N. Engl. J. Med. 357, 2371–2379 (2007).

  103. 103.

    Childhood obesity—the shape of things to come. N. Engl. J. Med. 357, 2325–2327 (2007).

  104. 104.

    et al. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 352, 1138–1145 (2005).

  105. 105.

    Childhood obesity, other cardiovascular risk factors, and premature death. N. Engl. J. Med. 362, 485–493 (2010).

  106. 106.

    et al. Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study). Am. J. Cardiol. 98, 1234–1237 (2006).

  107. 107.

    et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N. Engl. J. Med. 364, 1315–1325 (2011).

  108. 108.

    & Association of body mass index and obesity measured in early childhood with risk of coronary heart disease and stroke in middle age: findings from the aberdeen children of the 1950s prospective cohort study. Circulation 111, 1891–1896 (2005).

  109. 109.

    et al. Association of body mass index measured in childhood, adolescence, and young adulthood with risk of ischemic heart disease and stroke: findings from 3 historical cohort studies. Am. J. Clin. Nutr. 83, 767–773 (2006).

  110. 110.

    , & Relationship of childhood weight status to morbidity in adults. HSMHA Health Rep. 86, 273–284 (1971).

  111. 111.

    , & A 40-year history of overweight children in Stockholm: life-time overweight, morbidity, and mortality. Int. J. Obes. Relat. Metab. Disord. 18, 585–590 (1994).

  112. 112.

    et al. Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 103, 1546–1550 (2001).

  113. 113.

    , & Efficacy of exercise for treating overweight in children and adolescents: a systematic review. Int. J. Obes. (Lond.) 30, 1027–1040 (2006).

  114. 114.

    et al. Interventions for treating obesity in children. Cochrane Database of Systematic Reviews Issue 1. Art. No.: CD001872. doi: 10.1002/14651858.CD001872.pub2 (2009).

  115. 115.

    US FDA. News release. Abbott Laboratories agrees to withdraw its obesity drug Meridia [online], , (2010).

  116. 116.

    & Systematic review of school-based interventions that focus on changing dietary intake and physical activity levels to prevent childhood obesity: an update to the obesity guidance produced by the National Institute for Health and Clinical Excellence. Obes. Rev. 10, 110–141 (2009).

  117. 117.

    et al. Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial. JAMA 304, 1795–1802 (2010).

  118. 118.

    Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health. JAMA 288, 1622–1631 (2002).

  119. 119.

    , & Changes of cardiovascular risk factors in obese children effects of inpatient and outpatient interventions. J. Pediatr. Gastroenterol. Nutr. 43, 506–511 (2006).

  120. 120.

    , , & Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 114, 1569–1573 (2004).

  121. 121.

    et al. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA 297, 2697–2704 (2007).

  122. 122.

    , , & Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study. Arch. Dis. Child 94, 437–442 (2009).

  123. 123.

    et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 44, 458–465 (2006).

  124. 124.

    , , , & Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 25, 89–94 (2002).

  125. 125.

    , , & Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents. Pediatr. Diabetes 10, 5–13 (2008).

  126. 126.

    , , & Obesity and low-grade inflammation: a paediatric perspective. Obes. Rev. 11, 118–126 (2010).

  127. 127.

    & The genetics of obesity. Curr. Diab. Rep. 10, 498–505 (2010).

  128. 128.

    et al. Testing a model of physical activity and obesity tracking from youth to adulthood: the cardiovascular risk in young Finns study. Int. J. Obes. (Lond.) 31, 521–527 (2007).

  129. 129.

    et al. Association of Pathobiologic Determinants of Atherosclerosis in Youth risk score and 15-year change in risk score with carotid artery intima–media thickness in young adults (from the Cardiovascular Risk in Young Finns Study). Am. J. Cardiol. 100, 1124–1129 (2007).

  130. 130.

    , , , & Tracking of blood lipids and blood pressures in school age children: the Muscatine study. Circulation 58, 626–634 (1978).

  131. 131.

    & Does childhood obesity track into adulthood? Crit. Rev. Food Sci. Nutr. 33, 423–430 (1993).

  132. 132.

    & Risk in childhood of development of severe adult obesity: retrospective, population-based case-cohort study. Am. J. Epidemiol. 127, 104–113 (1988).

  133. 133.

    et al. Overweight and obesity from childhood to adulthood: a follow-up of participants in the 1985 Australian Schools Health and Fitness Survey. Med. J. Aust. 186, 458–460 (2007).

  134. 134.

    , & Body mass index and height from childhood to adulthood in the 1958 British born cohort. Am. J. Clin. Nutr. 66, 1094–1101 (1997).

  135. 135.

    et al. Predicting adult metabolic syndrome from childhood body mass index: follow-up of the New Delhi birth cohort. Arch. Dis. Child. 94, 768–774 (2009).

  136. 136.

    Childhood overweight and maturational timing in the development of adult overweight and fatness: the Newton Girls Study and its follow-up. Pediatrics 116, 620–627 (2005).

Download references

Author information

Affiliations

  1. The Children's Hospital, Department of Pediatrics, University of Colorado School of Medicine, Building A, 13123 East 16th Avenue, Aurora, CO 80045, USA

    • Kristen J. Nadeau
    •  & Stephen R. Daniels
  2.  Barbara Davis Center for Childhood Diabetes, Department of Pediatrics, University of Colorado School of Medicine, 1775 Aurora Court, Aurora, CO 80045, USA

    • David M. Maahs
  3.  Department of Medicine, University of Colorado School of Medicine, 12801 East 17th Avenue, Aurora, CO 80045, USA

    • Robert H. Eckel

Authors

  1. Search for Kristen J. Nadeau in:

  2. Search for David M. Maahs in:

  3. Search for Stephen R. Daniels in:

  4. Search for Robert H. Eckel in:

Contributions

All authors contributed equally to discussion of content, writing, and reviewing/editing the manuscript before submission and after peer-review. K. J. Nadeau and D. M. Maahs also researched data for the article.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Kristen J. Nadeau.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrcardio.2011.86

Further reading